RPCEC00000313已完成未知
Administration of the CIGB-258 peptide in patients with COVID-19 under intensive therapy regimen (COVID-19)
Center for Genetic Engineering and Biotechnology (CIGB), in Havana0 个研究点目标入组 16 人开始时间: 2020年5月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 19 years 至 one（—）
- 性别
- All
入选标准
- •1) Virological diagnosis by PCR-RT of infection to SARS-CoV-2.
- •2) Patients with confirmed respiratory distress / multifocal interstitial pneumonia.
- •3) Need for oxygen therapy to maintain SO2> 93%.
- •4) Worsening of lung involvement, defined as one of the following criteria: a) Worsening of oxygen saturation> 3 percentage points or decrease in PaO2> 10%, with stable FiO2 in the last 24 hours; b) Need to increase FiO2 in order to maintain stable SO2 or new need for mechanical ventilation in the last 24 hours; c) Increase in the number and / or extension of the lung consolidation areas.
- •5) Express voluntariness of the patient, family member or impartial witness.
排除标准
- •- Pregnancy or lactation.
研究者
相似试验
招募中
不适用
VIDA studyCOVID-19 respiratory distressCOVID-19Respiration DisordersRespiratory Tract DiseasesCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusSevere Acute Respiratory SyndromeRPCEC00000321Center for Genetic Engineering and Biotechnology (CIGB), in Havana
已完成
1 期
Phase I with CIGB-814 in rheumatoid arthritis patientsArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRheumatoid ArthritisRPCEC00000238Center for Genetic Engineering and Biotechnology (CIGB), in Havana18
已完成
2 期
Application of CIGB-128 in keloid patients undergoing surgical exeresis.CicatrixKeloidsKeloid/surgeryGranulation TissueConnective TissueCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesFibrosisPathologic ProcessesRPCEC00000061Center for Genetic Engineering and Biotechnology (CIGB)45
已完成
1 期
CIGB500 in healthy volunteersHealthy volunteersHealthy VolunteersRPCEC00000017Center for Genetic Engineering and Biotechnology (CIGB), Havana City18
尚未招募
1 期
CENTAURO StudySolid malignant tumors.RPCEC00000102Center for Genetic Engineering and Biotechnology (CIGB), in Havana.